Journal of Antimicrobial Chemotherapy, 0305-7453

Journal

Publications

  1. Published
  2. Published

    In-vitro activity of quinolones and macrolides against mycobacteria

    Laura Piddock, Sep 1994, In: Journal of Antimicrobial Chemotherapy. 34, 3, p. 343-51 9 p.

    Research output: Contribution to journalArticlepeer-review

  3. Published
  4. E-pub ahead of print
  5. Published

    Induction of beta-lactamases in gram-negative bacilli

    Laura Piddock, Nov 1987, In: Journal of Antimicrobial Chemotherapy. 20, 5, p. 767-8 2 p.

    Research output: Contribution to journalArticlepeer-review

  6. Published

    The antimicrobial activity of cefpirome, a new cephalosporin

    Laura Piddock, Apr 1985, In: Journal of Antimicrobial Chemotherapy. 15, 4, p. 449-56 8 p.

    Research output: Contribution to journalArticlepeer-review

  7. Published

    The in-vitro activity of Ro 17-2301, a new monobactam, compared with other antimicrobial agents

    Laura Piddock, Feb 1985, In: Journal of Antimicrobial Chemotherapy. 15, 2, p. 193-200 8 p.

    Research output: Contribution to journalArticlepeer-review

  8. Published

    The urgent need for new antibacterial agents

    Laura Piddock, Sep 2011, In: Journal of Antimicrobial Chemotherapy. 66, 9, p. 1939-40 2 p.

    Research output: Contribution to journalArticlepeer-review

  9. Published

    gyrA of ofloxacin-resistant clinical isolates of Mycobacterium tuberculosis from Hong Kong

    Laura Piddock, May 1996, In: Journal of Antimicrobial Chemotherapy. 37, 5, p. 1032-4 3 p.

    Research output: Contribution to journalArticlepeer-review

  10. Published

    Accumulation of rifampicin by Escherichia coli and Staphylococcus aureus

    Laura Piddock, Nov 1998, In: Journal of Antimicrobial Chemotherapy. 42, 5, p. 597-603 7 p.

    Research output: Contribution to journalArticlepeer-review

  11. Published
  12. Published

    Effective antibacterials: at what cost? The economics of antibacterial resistance and its control

    Laura Piddock, Sep 2011, In: Journal of Antimicrobial Chemotherapy. 66, 9, p. 1948-53 6 p.

    Research output: Contribution to journalArticlepeer-review

  13. Published
  14. Published

    The importance of efflux pumps in bacterial antibiotic resistance

    Mark Webber & Laura Piddock, 1 Jan 2003, In: Journal of Antimicrobial Chemotherapy. 51, p. 9-11 3 p.

    Research output: Contribution to journalArticle

  15. Published

    Triclosan resistance in Salmonella enterica serovar Typhimurium

    Mark Webber & Laura Piddock, 1 Apr 2008, In: Journal of Antimicrobial Chemotherapy. 62, 1, p. 83-91 9 p.

    Research output: Contribution to journalArticle

  16. Published
  17. Published
  18. Published

    Quinolone-resistant gyrase mutants demonstrate decreased susceptibility to triclosan

    Mark Webber, Michelle MC Buckner & Laura Piddock, 1 Oct 2017, In: Journal of Antimicrobial Chemotherapy. 72, 10, p. 2755-2763 9 p.

    Research output: Contribution to journalArticlepeer-review

  19. Published
  20. Published

    The effect of mutations in the SOS response on the kinetics of quinolone killing

    Laura Piddock, Dec 1989, In: Journal of Antimicrobial Chemotherapy. 24, 6, p. 863-73 11 p.

    Research output: Contribution to journalArticlepeer-review

  21. Published

    Using HIV resistance tests in clinical practice.

    Stephen Taylor, 1 Aug 2009, In: Journal of Antimicrobial Chemotherapy. 64, 2, p. 218-22 5 p.

    Research output: Contribution to journalReview article

  22. Published
  23. E-pub ahead of print

    Tandem amplification of the vanM gene cluster drives vancomycin resistance in vancomycin-variable enterococci

    Willem van Schaik, 19 Nov 2019, (E-pub ahead of print) In: Journal of Antimicrobial Chemotherapy. 9 p.

    Research output: Contribution to journalArticlepeer-review

  24. Published
  25. Published

    Bacterial efflux pump inhibitors from natural sources

    Laura Piddock, 18 Apr 2007, In: Journal of Antimicrobial Chemotherapy. 59, 6, p. 1247-60 14 p.

    Research output: Contribution to journalArticle

  26. Published
  27. Published

    Surveillance of HIV antiretrviral drug resistance in treated individuals in England

    Paul Scott, Pat Cane, 12 Feb 2004, In: Journal of Antimicrobial Chemotherapy. 53, p. 469-473 5 p.

    Research output: Contribution to journalArticle

  28. E-pub ahead of print
  29. Published
  30. Published

    Efflux in Acinetobacter baumannii can be determined by measuring accumulation of H33342 (bis-benzamide)

    Laura Piddock, Jul 2013, In: Journal of Antimicrobial Chemotherapy. 68, 7, p. 1594-600 7 p.

    Research output: Contribution to journalArticlepeer-review

  31. Published
  32. Published

    Accumulation of garenoxacin by Bacteroides fragilis compared with that of five fluoroquinolones

    Vito Ricci & Laura Piddock, Oct 2003, In: Journal of Antimicrobial Chemotherapy. 52, 4, p. 605-9 5 p.

    Research output: Contribution to journalArticlepeer-review

  33. Published
  34. Published
  35. Published
  36. Published
  37. Published
  38. Published
  39. Published
  40. Published
  41. Published
  42. Published
  43. Published
  44. Published
  45. Published
  46. Published
  47. Published
  48. Published
  49. Published

    Mechanism of quinolone uptake into bacterial cells

    Laura Piddock, Apr 1991, In: Journal of Antimicrobial Chemotherapy. 27, 4, p. 399-403 5 p.

    Research output: Contribution to journalArticlepeer-review

  50. Published

    Newer mechanisms of resistance to beta-lactam antibiotics in gram-negative bacteria

    Laura Piddock, Sep 1985, In: Journal of Antimicrobial Chemotherapy. 16, 3, p. 279-84 6 p.

    Research output: Contribution to journalArticlepeer-review

  51. Published
  52. Published

    Accumulation of five fluoroquinolones by Mycobacterium tuberculosis H37R

    Laura Piddock & Vito Ricci, 1 Dec 2001, In: Journal of Antimicrobial Chemotherapy. 48, 6, p. 787-91 5 p.

    Research output: Contribution to journalArticle

  53. Published
  54. Published

    Ciprofloxacin resistance in Salmonella serotypes

    Laura Piddock, Dec 1990, In: Journal of Antimicrobial Chemotherapy. 26, 6, p. 853

    Research output: Contribution to journalArticlepeer-review

  55. Published
  56. Published

    Activity of faropenem for ciprofloxacin-resistant bacteria

    Laura Piddock & Mark Webber, 13 Aug 2003, In: Journal of Antimicrobial Chemotherapy. 52, 3, p. 500-2 3 p.

    Research output: Contribution to journalArticle

  57. Published
  58. Published

    Non-gyrA-mediated ciprofloxacin resistance in laboratory mutants of Streptococcus pneumoniae

    Laura Piddock, May 1997, In: Journal of Antimicrobial Chemotherapy. 39, 5, p. 609-15 7 p.

    Research output: Contribution to journalArticlepeer-review

  59. Published

    The effect of altered porin expression in Escherichia coli upon susceptibility to 4-quinolones

    Laura Piddock, Oct 1986, In: Journal of Antimicrobial Chemotherapy. 18, 4, p. 547-9 3 p.

    Research output: Contribution to journalArticlepeer-review

  60. Published

    Quinolone resistance and Campylobacter spp

    Laura Piddock, Dec 1995, In: Journal of Antimicrobial Chemotherapy. 36, 6, p. 891-8 8 p.

    Research output: Contribution to journalArticlepeer-review

  61. Published
  62. Published

    Post-therapy multiply resistant mutant of Pseduomonas aeruginosa

    Laura Piddock, 1 Jan 2002, In: Journal of Antimicrobial Chemotherapy. 49, 1, p. 215 1 p.

    Research output: Contribution to journalArticle

  63. Published

    Accumulation of KRM-1648 by Mycobacterium aurum and Mycobacterium tuberculosis

    Laura Piddock & Vito Ricci, May 2000, In: Journal of Antimicrobial Chemotherapy. 45, 5, p. 681-4 4 p.

    Research output: Contribution to journalArticlepeer-review

  64. Published
  65. Published
  66. Published
  67. Published
  68. Published
  69. Published
  70. Published

    Antimicrobial activity and accumulation of moxifloxacin in quinolone-susceptible bacteria

    Laura Piddock, May 1999, In: Journal of Antimicrobial Chemotherapy. 43 Suppl B, p. 39-42 4 p.

    Research output: Contribution to journalArticlepeer-review

  71. Published

    Quinolone accumulation by Pseudomonas aeruginosa, Staphylococcus aureus and Escherichia coli

    Laura Piddock, Vito Ricci, Jan 1999, In: Journal of Antimicrobial Chemotherapy. 43, 1, p. 61-70 10 p.

    Research output: Contribution to journalArticlepeer-review

  72. Published

    Mechanisms of resistance to quinolones and clinical perspectives

    Laura Piddock, Apr 1989, In: Journal of Antimicrobial Chemotherapy. 23, 4, p. 475-80 6 p.

    Research output: Contribution to journalArticlepeer-review

  73. Published

    Selection and characterization of cefepime-resistant gram-negative bacteria

    Laura Piddock & Deborah Griggs, Nov 1991, In: Journal of Antimicrobial Chemotherapy. 28, 5, p. 669-76 8 p.

    Research output: Contribution to journalArticlepeer-review

  74. Published

    High-level quinolone resistance in Pseudomonas aeruginosa

    Laura Piddock & Peter Hawkey, Aug 1992, In: Journal of Antimicrobial Chemotherapy. 30, 2, p. 229-31 3 p.

    Research output: Contribution to journalArticlepeer-review

  75. Published
  76. Published

    Selection of quinolone-resistant mutants of Haemophilus influenzae and Streptococcus pneumoniae

    Laura Piddock, Jul 1992, In: Journal of Antimicrobial Chemotherapy. 30, 1, p. 109-10 2 p.

    Research output: Contribution to journalArticlepeer-review

  77. Published
  78. Published

    Teixobactin, the first of a new class of antibiotics discovered by iChip technology?

    Laura Piddock, Oct 2015, In: Journal of Antimicrobial Chemotherapy. 70, 10, p. 2679-80 2 p.

    Research output: Contribution to journalArticlepeer-review

  79. Published
  80. Published

    Should quinolones be used in the treatment of bacterial infections in neutropenic patients?

    Laura Piddock, Nov 1993, In: Journal of Antimicrobial Chemotherapy. 32, 5, p. 771-4 4 p.

    Research output: Contribution to journalArticlepeer-review

  81. Published
  82. Published
  83. Published

    The PBPs of Bacteroides fragilis

    Laura Piddock, Sep 1983, In: Journal of Antimicrobial Chemotherapy. 12, 3, p. 292

    Research output: Contribution to journalArticlepeer-review

  84. Published
  85. Published
  86. Published

    Plasmid-mediated complementation of gyrA and gyrB in fluoroquinolone-resistant Bacteroides fragilis

    Laura Piddock, Sep 2003, In: Journal of Antimicrobial Chemotherapy. 52, 3, p. 481-4 4 p.

    Research output: Contribution to journalArticlepeer-review

  87. Published
  88. E-pub ahead of print
  89. Published
  90. Published

    The accumulation of five antibacterial agents in porin-deficient mutants of Escherichia coli

    Laura Piddock, Aug 1993, In: Journal of Antimicrobial Chemotherapy. 32, 2, p. 195-213 19 p.

    Research output: Contribution to journalArticlepeer-review

  91. Published
  92. Published
  93. Published

    CTX-M ESBL-producing Enterobacteriaceae: estimated prevalence in adults in England in 2014

    Peter Hawkey, 1 May 2018, In: Journal of Antimicrobial Chemotherapy. 73, 5, p. 1368-1388 21 p.

    Research output: Contribution to journalArticlepeer-review

  94. Published

    Interaction of divalent cations, quinolones and bacteria

    Laura Piddock, Oct 1994, In: Journal of Antimicrobial Chemotherapy. 34, 4, p. 465-83 19 p.

    Research output: Contribution to journalArticlepeer-review

  95. E-pub ahead of print

    Occurrence of colistin-resistant hypervirulent Klebsiella variicola

    Alan McNally, 27 Jul 2018, (E-pub ahead of print) In: Journal of Antimicrobial Chemotherapy.

    Research output: Contribution to journalArticlepeer-review

  96. Published

    The control of class I beta-lactamase expression in Enterobacteriaceae and Pseudomonas aeruginosa

    Julia Lodge & Laura Piddock, Aug 1991, In: Journal of Antimicrobial Chemotherapy. 28, 2, p. 167-72 6 p.

    Research output: Contribution to journalArticlepeer-review

  97. Published

    CTX-M: Changing the face of ESBLs in the UK

    Peter Hawkey, 1 Jan 2005, In: Journal of Antimicrobial Chemotherapy. p. 451-54 4 p.

    Research output: Contribution to journalArticle

  98. Published

    Discovery research: the scientific challenge of finding new antibiotics

    Laura Piddock, Sep 2011, In: Journal of Antimicrobial Chemotherapy. 66, 9, p. 1941-4 4 p.

    Research output: Contribution to journalArticlepeer-review

  99. Published

    blaNDM-21, a new variant of blaNDM in an Escherichia coli clinical isolate carrying blaCTX-M-55 and rmtB

    Alan McNally, Sep 2018, In: Journal of Antimicrobial Chemotherapy. 73, 9, p. 2336-2339 4 p.

    Research output: Contribution to journalArticlepeer-review

  100. Published
Previous 1 2 Next